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The altered metabolism of renal structural glycoproteins in
insulin-dependent diabetes leads to the continuing accumula-
tion of basement membrane-like material. This abnormality is
evidenced by progressive thickening of the glomerular and
tubular basement membrane (BM) and deposition of BM-like
material in the glomerular mesangium [1, 2]. Contrary to
previous prevailing belief, the abnormal metabolism of renal
BM glycoproteins is an early event in diabetes. Glomerular BM
mass is significantly increased 4 days after the induction of
diabetes in rats [3]. Since glomerular BM has a turnover of 23 to
100 days [41, increased synthesis, rather than decreased break-
down, is a more likely explanation for the rapid accumulation of
BM. In support of this concept, studies of aminoacid incorpo-
ration into glomerular BM in vivo have demonstrated an
accelerated rate of polypeptide synthesis and proline hydroxyl-
ation after 9 days of diabetes [5]. Additional evidence for the
increased synthesis of renal BM glycoproteins is derived from
studies of the specific glycosyltransferases involved in the
postribosomal glycosylation of newly formed BM peptides. The
activity of collagen glucosyltransferase, the enzyme attaching
glucose to hydroxylysine-linked galactose, is increased in the
renal cortex of alloxan-induced or spontaneously diabetic ani-
mals [6—8].
Glycogen is another compound which characteristically accu-
mulates in the diabetic kidney. Its cortical content is increased
two- to five-fold during the first 48 hr of diabetes in the rat [9,
10]. The deposition of glycogen continues as the disease pro-
gresses in untreated animals so that cortical glycogen content is
30 to 50 times greater than in controls at 1 and 6 months,
respectively, after the onset of diabetes [11, 12].
Uridine diphosphosugars (UDP-sugars) are the donors of
carbohydrate groups in the glycosyl transfer reactions occur-
ring in the formation of glycoproteins. In addition to its partici-
pation in glycoprotein synthesis, UDP-glucose (UDPG) is in-
volved in the glucosyl group transfer reaction in the synthesis of
glycogen. If the synthesis of glycoproteins and glycogen is
enhanced, an increase in the synthesis of UDP-sugars may be
anticipated in the diabetic renal cortex. The possibility that the
synthesis of UDP-sugars may be altered is important because
the bioavailability of these compounds may influence the for-
mation of glycoproteins and glycogen El 3].
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The endogenous pool of uridine 5'-triphosphate (UTP), the
immediate precursor for UDP-sugar formation (Fig. 1), is
expanded in the renal cortex of rats 48 hr after the induction of
diabetes [9, 14]. However, it is questionable if this increase in
UTP pool size would enhance the formation of UDP derivatives
because their synthesis in vitro is strictly regulated by feedback
inhibition of UDPG-pyrophosphorylase (EC 2.7.7.9) and glu-
cosamine synthetase (EC 2.6.1.16) by UDP-glucose (UDPG)
and UDP-N-acetylglucosamine (UDPAG), respectively [15, 16]
(Fig. 1).
The purpose of the study was to assess the relationship of the
UTP pool size to the rates of formation and pool sizes of UDP-
sugars and UDP-amino sugars in the renal cortex of rats shortly
after the onset of streptozotocin-induced diabetes. In addition,
the effects of exogenously induced alterations in the UTP pool
on the pools of its UDP derivatives were investigated.
Methods
Male Fisher rats, weighing 160 to 200 g, were used. Following
insertion of permanent cannulae into the left femoral vein [9],
the rats recovered from surgery for 14 days before experiments
were carried out. The animals had free access to food and water
throughout the duration of the studies. Diabetes was induced by
the i.v. injection of 50 mg/kg streptozotocin (U-9889, a gift from
the Upjohn Co., Kalamazoo, Michigan) dissolved in 0.15 M
sodium chloride acidified to pH 4.0 with 0.1 M citrate buffer. A
control group of animals injected with the same volume of
acidified 0.15 M sodium chloride was included in each experi-
ment. Eighty control and 70 diabetic rats were used.
A continuous infusion of 0.15 M sodium chloride at a rate of 3
Id/mm was started 24 hr before the termination of the experi-
ments. In one experiment, in order to expand the endogenous
UTP pool, sodium orotate was infused [14] at a rate of 1 p.mol/
hr in groups of control and diabetic rats. In a separate experi-
ment, in order to deplete the UTP pool, adenine hydrochloride
was infused at a rate of 4 mol/hr in a group of control animals.
Previous experiments have demonstrated that orotate or ade-
nine given at the above rates does not result in renal damage
from intratubular crystallization [14]. To study the incorpo-
ration of pyrimidine precursors into nucleotides, radiolabeled
orotate was added to all infusates during the final 2 hr of
infusion period. In rats given sodium orotate, radiolabeled
precursors were not used. Each animal received 60 Ci of [5-
3H]orotic acid (sp act 20 Ci/mmole) and a total of 0.1 mo1e of
orotate. In previous studies in which this method was applied,
676
Uridine diphosphosugar synthesis in the diabetic rat 677
linear increases in UTP and RNA specific radioactivities were
demonstrated in the diabetic and control renal cortex over the
2-hr infusion of radiolabeled orotate [9].
All experiments were terminated 48 hr after the administra-
tion of streptozotocin. At the end of the infusion period, the left
kidneys were exteriorized through a lumbar incision and a
sample of renal cortex was obtained with immediate freezing in
liquid nitrogen [9]. Blood samples were obtained by cardiac
puncture, and plasma was separated for the measurement of
glucose by the glucose oxidase method. In all streptozotocin-
injected rats plasma glucose concentrations were greater than
300 mg/dl. Medullary fragments included in the frozen cortical
samples were scraped from the cortex under liquid nitrogen.
Samples weighing 200 to 300 mg were pulverized in a precooled
stainless steel mortar and placed in 0.2 M perchloric acid at
2° C. As an internal standard 0.25 Ci of [2-'4C]UTP was added
to each sample for assessment of UTP recovery. The tissue was
homogenized in 0.2 M perchloric acid; the acid-soluble fraction
was neutralized immediately with I M potassium hydroxide and
was lyophilized for later chromatographic analysis [9].
RNA and DNA were extracted from the acid-insoluble frac-
tion and were quantified by their pentose content as determined
by the orcinol and diphenylamine reactions respectively [9].
With these methods 1 p.g of yeast RNA (type I, Sigma Chemical
Co., St. Louis, Missouri) is equivalent to 0.6 pg of ribose, and 1
ig of calf thymus DNA (type I, Sigma) is equivalent to 0.13 i.g
of deoxyribose.
High-pressure liquid chromatographic analyses. Lyophilized
samples were resuspended in 0.15 to 0.2 ml of distilled water
and centrifuged at 107,000 x g for 30 mm. UTP was quantitated
in 22-sl samples of the supernatant by anion-exchange chroma-
tography as described previously [9]. In each separate experi-
ment, equal portions of the remaining supernatants of the
nucleotide extracts derived from the left renal cortices of three
to 11 (mean of seven) rats in control and experimental groups
were pooled for UDP-sugar analysis.
Quantitative chromatographic analysis of UDP-sugars was
carried out by a method combining reversed-phase and anion-
exchange separation modes using 4.6 x 25 cm columns of
Zorbax-NH2 (DuPont Co., Wilmington, Delaware). Analyses
were performed at room temperature in a Beckman 332 liquid
chromatograph system (Beckman Instruments Inc., Fullerton,
California). Samples were eluted at a flow of 1 mllmin with a
concave gradient formed by (1) an initial buffer consisting of
0.08 M potassium phosphate, pH 2.8 containing 35% acetonitrile
and (2) a final buffer consisting of 0.8 M KH2PO4, pH 3.6. To
ensure a steady baseline, an identical chromatographic column
was connected to the reference side of the absorbance detector;
eluant was forced through it at the same flow rate as on the
sample side. Peaks were detected by simultaneous monitoring
at 254 and 280 nm and their areas quantitated using a Waters'
Data Module electronic integrator (Waters Associates Inc.,
Milford, Massachusetts). With this method, UDP, UDPG,
UDP-glucuronic acid (UDPGA), UDPAG, and UDP-N-acetyl
galactosamine (UDPA-GAL) were separated in 70 mm. UDP-
galactose (UDP-GAL), UDP-mannose, and UDP-xylose eluted
as a single peak and are referred to as UDP-GAL in this study.
The differences in the chromatographic quantitation of UDP
derivatives in duplicate analyses varied between 3 and 10% for
UDPAG and UDPGA, respectively. Peaks were identified
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Fig. 1. Simplified schema of the metabolic pathways for the synthesis
and utilization of UPD derivatives. The reactions catalyzed by UDPG-
pyrophosphorylase (1) and glucosamine synthetase (2) are in-
dicated. Abbreviations are: PRPP, 5-phosphoribosyl-l-pyrophosphate;
OMP, orotidine 5'-phosphate; UTP, uridine 5'-triphosphate; UDPG,
uridine 5'-diphosphoglucose; UDPG, uridine 5'-diphosphoglucuronic
acid; UDPAG, uridine 5'-diphospho-N-acetyl-glucosamine; UDP-
GAL, uridine 5'-diphosphogalactose; UDPG-GAL, uridine 5'-diphos-
pho-N-acetylgalactosamine; BM, basement membrane; GAG,
glycosaminoglycans.
according to: (1) retention times of purified standards, (2) ratio
of absorbancy at 254 and 280 nm, (3) co-chromatography of
radiolabeled UDP-sugars. Column effluents were collected in
0.2 ml fractions for determination of 3H and '4C radioactivity.
The resolution of the UDP-sugars did not vary appreciably
between chromatographic columns but was influenced by the
number of tests done with each column. The quantitation of
UDPG exhibited interference in some analyses by incomplete
separation from an unidentified compound which was not a
uracil derivative and did not contain radioactivity. This difficul-
ty was resolved by combining specific enzymatic methods [17]
for the measurement of UDP-sugars with the original chromato-
graphic methods described previously. Quantitative enzymatic
oxidation of UDPG to UDPGA was carried out in 20 to 50 l of
the final sample prepared for chromatographic analysis. Sam-
ples were incubated for 15 mm with 80 to 200 mU of bovine liver
UDPG dehydrogenase (EC 1.1.1.22, type III, Sigma) in an
assay system containing 3 m nicotinamide adenine dinucleo-
tide (NAD) and 0.5 M glycine buffer, pH 8.7 at room tempera-
ture [18]. The same volume of the final nucleotide extract was
incubated as a control sample without enzyme under identical
conditions. A 29-pJ portion of the final enzymatic or control
incubation mixtures was used for chromatographic quantita-
tion. The amount of UDPG in the sample was estimated as the
increase in UDPGA after enzymatic oxidation of UDPG. When
[glucose-'4C(U)]UDPG (sp act 334 mCilmmole) was used as
internal standard, 92 to 102% of the radioactivity added was
recovered as [14C]UDPGA. The preparation of UDPG dehydro-
genase used did not contain UDPG pyrophosphorylase (EC
5.1.3.2) activity as demonstrated by the lack of incorporation of
'4C from the internal standard ['4C]UTP into UDPG or UDPGA
in tissue extracts in which UTP and glucose 1-phosphate were
present.
Standards and radiolabeled compounds. All standards were
obtained from Sigma Chemical Co., St. Louis, Missouri. Nude-
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otide standards for chromatographic analyses were prepared as
mixtures of purified nucleotides in proportions similar to those
found in the rat renal cortex. Radiolabeled compounds were
obtained from New England Nuclear Corp. (Boston, Massachu-
setts). The radiochemical purity of all nucleotide standards used
was tested by high-pressure liquid chromatography at the end of
each experiment. The purity of [2-'4C]UTP, [glucose-'4C(U)]-
UDPG, [galactose- '4C(U)]UDP-GAL, [galactosamine- 1-
'4C]UDPG-GAL varied from 80 to 100%.
Presentation of data and statistical analysis. RNA and DNA
were expressed as their pentose equivalents. Values for nucleo-
tide content were corrected according to the final UTP recovery
for extraction and analytical methods. This recovery varied
between 69 and 94%. Incorporation values are presented as
fractions of the dpm infused/200 g of body wt, correcting for the
small changes in mean weight between rats in different experi-
mental groups. Results are expressed per unit DNA because:
(1) It is the reference of choice to evaluate changes in tissue
composition during rapid growth [19], (2) is the only renal
component that remains constant during early diabetic renal
growth [20], and (3) is equivalent to the expression of results per
cell in the renal cortex because of the uniploidy of its cells. To
assess tissue concentration of nucleotides, the results are
expressed per unit of frozen tissue weight also.
All results are presented as means SEM withthe number of
observations in parenthesis. The statistical significance of the
differences was determined by Student's t test for nonpaired
variables when groups of control and experimental animals
from one experiment were compared. When the mean values to
be compared originated from pairs of control and experimental
samples in separate experiments, the Student's t test for paired
variables was used.
Results
Effects of short-term diabetes on the renal cortical cell
content of UDP-sugars and UDP-amino sugars. In normal
renal cortex the pool of UTP was appreciably larger than any of
the pools of the UDP-sugars or UDP-amino sugars which are
derived from it (Table 1). Further, the size of the total UDP-
amino sugar pool was 50% greater than that of the total UDP-
sugar pool. UDPAG was the most abundant single compound,
having the largest pool size (Table 1) and a tissue concentration
of 168 11 nmole/g. The concentration of UDPG was 117 11
nmole/g with a cellular pool which was about two-thirds the size
of the UDPAG pool (Table 1).
In the diabetic renal cortex, 48 hr after the injection of
streptozotocin, there were marked changes in the contents of
uracil nucleotides. Both the UTP pool and the pools of its
metabolic derivatives were consistently increased in each of the
seven experiments (Table 1), except for the UDP-GAL pool in
which no change was demonstrated. The alteration in nucleo-
tide content was not of the same magnitude in all pools because
there was a greater increase in the size of the UDP-sugar and
UDP-amino sugar pools than in the UTP pool (Table 1). The
magnitude of the change in the pools of UDP-amino sugars was
greater than in the pools of UDP-sugars. The size of the total
UDP-amino sugar pool was then about 100% greater than the
total UDP-sugar pool in the diabetic cortex. The greatest
change was found in the size of the pool and in tissue concentra-
tion of UDPAG which increased by 68 and 47%, respectively,
Table 1. Effects of experimental diabetes on the cellular pools of
UTP, UDP-sugars, and UDP-amino sugars in the rat renal cortex
Cortical contents
nmolelmg DNA
P
Difference
%
increaseControP' Diabeticb
UDPAG (7)' 367 23 606 23 <0.001 68 9
UDPA-GAL (7) 131 13 207 21 <0.005 59 9
UDPG (6) 256 23 355 36 <0.05 41 15
UDPGA (7) 147 16 229 23 <0.001 59 10
UDP-GAL (4) 75 14 74 14 NS
UTP (7) 483 24 531 36 <0.02 10 2
Values are means SEM.
b Measurements were made in pooled samples of tissue extracts from
groups of diabetic and control rats in each experiment.
Values in parenthesis represent number of individual experiments.
(concentration in diabetic cortex, 248 9 nmole/g). There were
also significant increases in the pools of UDPG and of UDPGA,
(Table 1) which is the immediate product of UDPG oxidation
(Fig. 1).
Effects of short-term diabetes on the incorporation ofpyrimi-
dine precursors into renal cortical UDP-sugars and UDP-
amino sugars. A continuous 2-hr infusion of small amounts of
[3H]orotate resulted in substantial labeling of UTP and all UDP
derivatives. In the control animals the greatest incorporation of
precursor was in UTP. The specific radioactivity of the UTP
pool was 50% greater than in UDPAG and UDPG (Table 2). The
incorporation of precursor into UDP-sugars and UDP-amino
sugars was similar. However, the resulting specific radioactiv-
ity of the UDPG pool was significantly greater than the UDPAG
pool (P < 0.025).
In diabetic rats there was a significant increase in the
incorporation of precursor into UTP. In addition [3H]orotate
incorporation into UDP-sugars and UDP-amino sugars was
increased also, except for UDP-GAL where the difference was
not significant (Table 2). This increase in precursor incorpo-
ration was not uniform in all pools. The incorporation into
UDPAG was 74% greater than in controls while the correspond-
ing increases in UDPG and UDPGA were 41 and 77%,
respectively.
The augmented incorporation into UDP derivatives in the
diabetic cortex was not associated with substantial increases in
the specific radioactivity of the pools measured (Table 2).
However, the specific radioactivity of the UTP pool increased
by 25% which was significant. To rule out the possibility that
this increase in UTP specific radioactivity was the primary
cause for the greater incorporation of labeled precursor into the
UDPAG and UDPG pools, we factored the total radioactivity
found in these pools by the UTP specific radioactivity. The
factoring resulted in corrected incorporation values which were
still greater in diabetic animals (Table 2).
Effects of the administration of orotate or adenine on the
renal cortical pools of UDP-sugars and UDP-amino sugars.
The continuous 24-hr infusion of orotate resulted in significant
increases in the renal cortical pool of UTP in both control [440
12(10) vs. 645 26(10) nmole/mg DNA, P < 0.001] and
diabetic animals [502 12(9) vs. 797 36(10) nmole/mg DNA,
P < 0.001] although the increase was greater in the latter
(control 46%, diabetic 59%). In this experiment the expansion
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Table 2. Effects of experimental diabetes on the incorporation of radiolabeled orotate into UTP, UDP-sugars and
UDP-amino sugars in the rat renal cortex
Corrected
Precursor incorporationa
% of dpm infused/mg DNA
P
Specific radioactivitya
102 >< dpm/nmole
P
incorporationa
dpm/UTP sp act
Controib Diabetic" Control" Diabetic" Control" Diabeticb P
UDPAG (5)c 2.42 0.20 4.21 0.27 <0.001 127 9 145 14 NS 256 19 369 30 <0.005
UDPA-GAL (5) 0.82 0.06 1.28 0.12 <0.05 151 12 163 18 NS
UDPG (5) 2.36 0.24 3.34 0.39 <0.05 202 25 226 96 NS 243 36 305 65 <0.05
UDPGA (5) 1.11 0.14 1.97 0.24 <0.005 175 13 181 17 NS
UDP-GAL (4) 0.69 0.12 1.02 0.26 NS
UTP (6) 3.79 0.75 5.77 0.44 <0.05 183 15 229 27 <0.05
Values are means SEM.
Measurements were made in pooled samples of tissue extracts from groups of diabetic and control animals in each experiment.
Values in parenthesis are number of individual experiments.
of the UTP pooi was associated with appreciable increases in
the content of UDPAG and UDPG as measured in a pooled
sample of control or diabetic animals (Fig. 2). However, this
increase was of lesser magnitude in diabetics than in controls
although the final UDPAG and UDPG pools in the diabetic
were greater. The pool of UDPAG which was already expanded
in nontreated diabetics increased 12% after orotate infusion
while the corresponding increase for controls was 29%. Similar-
ly, the expanded pool of UDPG in the diabetic cortex was 21%
greater after orotate infusion; the normal pool of the control
cortex increased 31% after the same treatment (Fig. 2). The
pools of UDPA-GAL and UDPGA were minimally altered
following orotate administration.
In a separate experiment, the 24-hr infusion of adenine to
control animals resulted in a significant depletion of the UTP
pool [513 11(20) vs. 401 18(16) nmole/mg DNA, P K 0.0011
and in a marked decrease in [3H]orotate incorporation into UTP
[5.78 0.27(13) vs. 1.46 0.12(8) dpm infused/mg DNA, P <
0.001]. When a pooled sample of cortical extracts from treated
controls was analyzed, a 13 to 19% depletion in the cellular
pools of UDPAG, UDPA-GAL, UDPG, and UDPGA was
shown to occur concomitant with the loss of UTP (Fig. 3). In
addition, the amount of [3H]orotate incorporated into UDPG
decreased from 3.2% in control to 0.88% in adenine treated
animals. Similarly, the incorporation into UDPAG also de-
creased from 3.1 to 0.66%.
When the sizes of the cortical UTP and UDPG pools obtained
in each individual experiment were correlated, a significant,
positive correlation was found (Fig. 4).
Discussion
The development of the new chromatographic technique
described in this paper has permitted metabolic studies of the
more abundant UDP compounds present in the renal cortex.
Using this technique, the measured renal cortical concentra-
lions of UDPG is similar to values previously described for the
whole kidney [18].
The present studies demonstrate that the metabolic changes
in pyrimidine nucleotides described previously in the renal
cortex of the diabetic kidney are not limited to UTP and its
precursors (Fig. 1). There is also expansion of the UDP-sugar
and UDP-amino sugar pools which is greater than that of the
UTP pool itself. Previous studies have shown that the rapid
increase in the renal cortical content of UTP and in the
synthesis of pyrimidine nucleotides in the diabetic kidney can
be prevented by insulin replacement [9]. It is likely, therefore,
that the metabolic alterations in UDP derivatives are also
related to insulin deficiency.
The expansions of the UDPAG, UDPA-GAL, UDPG, and
UDPGA pools in diabetes are probably due to increased
synthesis rather than to decreased utilization. This possibility is
suggested by the marked increase in the incorporation of
radiolabeled orotate into each individual pool without alteration
in the specific radioactivity of these. Further, the increased
incorporation of radioactivity into UDPAG and UDPG is not
offset by utilizing the specific radioactivity of UTP for the
correction of the results. Consequently, the greater labeling of
UDP-sugars and UDP-amino sugars cannot be explained by the
increased amounts of label present in the UTP precursor pool.
The results of this study demonstrate the dependence of the
formation of renal cortical UDPAG and IJDPG on the size of
their immediate UTP precursor pooi. Expansion of the UTP
pool by providing exogenous orotate as substrate for pyrimidine
synthesis de novo [14] is followed by increases in the UDPAG
and UDPG pools. The change is of lesser magnitude in diabet-
ics, probably because in the diabetic cortex the pools are
already expanded markedly. Limiting the bioavailability of
phosphorybosylpyrophosphate for pyrimidine synthesis by the
administration of adenine [14, 21], thus depleting the UTP pool,
is also associated with decrement of the UDPGA and UDPG
pools. Analysis of the data obtained in this study shows that
cortical UDPG contents between 200 and 500 nmol/mg DNA
correlate directly with the size of the UTP pool. The importance
of the size of the UTP pool as a determinant of the synthesis of
UDP-sugars and UDP-amino sugars in vivo has been demon-
strated also in the liver of the rat in vivo [22, 23] and in vitro [24,
25]. The reasons for the absence of feedback control of the
synthesis of UDP- sugars and UDP-amino sugars by the expand-
ed UDPG and UDPAG pools in orotate-treated animals is
unclear. Although it has been demonstrated that the activity of
specific enzymes is rate limiting in the synthesis of these
compounds in vitro [15, 16], it is doubtful whether the same
occurs in vivo. One possibility is that variations in the tissue
concentrations of secondary inhibitors and activators such as
AMP and UTP [16, 26] may be determinants of enzymatic
activity in vivo.
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Fig. 2. Effects of orotae infusion on the cellular poois of UTP, UDP-
sugars and UDP-amino sugars in the renal cortex of diabetic and
control rats. All results were obtained in the same experiment. Pooled
samples of renal cortex from the left kidneys of 5 to 10 animals were
analyzed for each of the four groups.
Analysis of the metabolic changes in individual UDP deriva-
tives demonstrates that in the diabetic cortex, UDPAG presents
the greatest pool expansion and UDPAG and UDPGA the
greatest increase in precursor incorporation. There is, there-
fore, an abundance of substrates for the synthesis of glycosami-
noglycans. The concentration of heparan sulfates, the major
glycosaminoglycans in the mammalian renal cortex [27], has
been found to be increased in kidneys of diabetic patients [28].
Further, heparan sulfate is an important constituent of the
noncollagenous portion of the glomerular BM [29—31] and
glycosaminoglycans are actively synthetized by glomerular
cells in vitro [32] and deposited as part of BM material [33]. It is
possible that the increased bioavailability of its precursors and
the abnormal synthesis of glycosaminoglycans play an impor-
tant role in the deposition of BM material in the diabetic kidney.
The changes in UDPG pooi size, although smaller than for
UDPAG, and precursor incorporation into UDPG could have
metabolic significance. The UDPG pool has the fastest turnover
rate of all the renal cortical UDP derivatives as suggested by its
greater specific radioactivity after the infusion of [3H]orotate.
In the renal cortex, the bioavailability of UDPG appears to
affect glycogen synthesis because chronic orotate administra-
tion to rats is associated with increased content of glycogen
[34].
The extent to which the bioavailability of substrate modifies
the composition or net synthesis and deposition of structural
glycoproteins is not known. In the rat liver, depletion of
UDPAG is associated with decreased glycoprotein synthesis
[22, 35, 36], but the expansion of the pools of UDP-sugars and
UDP-amino sugars during 2 days of orotate administration does
not alter the rate of incorporation of glucosamine from UDP-
amino sugars into plasma glycoproteins [22]. The administra-
tion of orotate over a 6-month period results in thickening of the
glomerular BM in normal rat kidneys and in augmentation of the
glomerular BM thickening of diabetic rats [34]. Using the values
obtained in the present study and published figures for intracel-
lular water in the renal cortex [37, 38], the calculated concentra-
tion of UDPG in the normal renal cortex is 0.22 mM. At this
concentration maximal enzymatic activity would be expected of
the kidney glucosyltransferase involved in the formation of the
collagenous moiety of BM, according to the Km determined in a
UTP UDPAG UDPA-GAL UDPG UDPGA
Fig. 3. Effects of adenine infusion on the cellular poois of UTP, UDP-
sugars and UDP-amino sugars in the rat renal cortex. All results were
obtained in the same experiment. Pooled samples of renal cortex from
the left kidneys of 7 to 11 animals were analyzed for each of the two
groups.
purified enzyme preparation [39]. Thus, it could be assumed
that increases in UDPG would not enhance enzymatic activity.
However, it is difficult to predict enzyme action in vivo because
the activity of glycosyltransferases, as in the case with the
enzymes involved in UDP-sugar synthesis, is modified by
specific nucleotides [40, 41] which are likely to exert a regula-
tory role in the intact animal.
It is not know what fraction of the UDP derivatives formed in
excess in the diabetic kidney is utilized for the glycosylation of
proteins. Part of the normal metabolism of UDP-sugars and
UDP-amino sugars consists of hydrolytic breakdown by the
action of specific pyrophosphatases [42, 43]. Their activities are
modulated independently, in turn, by the tissue concentrations
of specific nucleotides [441. However, there is no information
available on the activity of nucleotide pyrophosphatases in the
kidney.
The effects of the bioavailability of precursors on the synthe-
sis of glycoproteins are exerted obviously in cellular compart-
ments in which precursors are accessible to the specific glyco-
syltransferases. This study deals only with the total tissue
content of UDP derivatives; comment on cellular compartmen-
tation of these pools would be speculative. The UTP pool seems
to be distributed in at least two compartments in cortical cells,
one serving as an RNA precursor and the other as a UDP-sugar
precursor [45]. Similarly, measurements of total cortical con-
tent of UDP derivatives do not take into account the structural
heterogeneity of the entire tissue. However, it is likely that the
observed alterations in the metabolism of UTP and UDP
derivatives in the whole renal cortex also occur in the glomeru-
Ii. Previous studies have shown rapid increases in the glomeru-
lar synthesis of pyrimidine nucleotides and in the content of
RNA after the induction of diabetes similar to the metabolic
changes described in the whole renal cortex [46].
It is theorized that an increase in the bioavailability of renal
UDP-sugars and UDP-amino sugars is necessary for the exag-
gerated synthesis of BM and BM-like material in the diabetic
kidney.
Summary. To assess the effects of streptozotocin-induced
diabetes on the substrates utilized in the formation of glycopro-
teins, the pools of uridine 5'-diphosphoglucose (UDPG), uridine
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Fig. 4. Relationship between the sizes of the cellular pools of UDPG
and of UTP in the rat renal cortex. Each data point represents
individual values from the same experiments as in Table 1 and Figures 1
5'-diphosphogalactose (UDP-GAL), uridine 5'-diphosphoglu-
curonic acid (UDPGA), and uridine 5'-diphospho N-acetyl
galactosamine (UDPA-GAL) were measured in the renal cortex
of control and over a 48-hr period in diabetic rats. In control
rats these pools measured: UDPG, 256 23; UDP-GAL, 75
14; UDPGA, 147 16; UDPAG, 367 23; UDPG-GAL, 131
13 nmoles/mg DNA. In diabetic rats, except for UDP-GAL, all
pools were increased 41 to 68%. The incorporation of radiola-
beled orotate was increased in all pools, except UDP-GAL, in
diabetic rats by 41 to 77% compared to control rats. The
incorporation into UDPG and UDPAG was increased even after
correction for the specific radioactivity of their immediate
precursor, uridine 5'-triphosphate (UTP). Expansion of the
UTP pool after orotate infusion was associated with an increase
in the size of the UDPG and UDPAG pools in both control and
diabetic rats. Depletion of the UTP pool after adenine infusion
in controls was associated with a decrease in all pools. This
study demonstrates that after the induction of diabetes there is a
rapid increase in the bioavailability of substrates utilized in the
synthesis of glycoproteins and glycosaminoglycans. It is theo-
rized that this increase is necessary for the augmented synthesis
of basement membrane-like material in the diabetic kidney.
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